Kura Oncology (KURA.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec19

Kura Oncology's CSO Francis Burrows Reports Disposition of Common Stock

21:30

Dec10

Kura Oncology Director Faheem Hasnain Disposes of Common Stock

21:05

Dec8

Kura Oncology and Kyowa Kirin Announce Positive Results of KOMET-007 Trial of KOMZIFTI in Treatment of Acute Myeloid Leukemia

15:30

Dec3

Kura Oncology to Host Virtual Meeting to Discuss Acute Myeloid Leukemia Drug Treatment Data

13:32

Dec2

Kura Oncology Completes First Commercial Sale in the US Post FDA Approval

13:03

Nov25

Kura Oncology Receives FDA Approval for KOMZIFTI™

22:17

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 20.75 M, Net Income -74.12 M, EPS -0.8456

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 15.29 M, Net Income -66.12 M, EPS -0.7549

May1

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 14.11 M, Net Income -57.43 M, EPS -0.6569

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change